CompletedNCT07526454
Electroconvulsive Therapy Versus Intravenous Ketamine in Treatment-Resistant Major Depressive Disorder
This study evaluated the effectiveness of ketamine for people with depression.
Medication studyAges 18–75Egypt
Understand this study
What did researchers investigate?
This study evaluated the effectiveness of ketamine for people with depression.
Who was this study for?
Listed age limits: 18 years to 75 years.
- Listed locations
- TantaSee all locations and recruitment
Study information
Study start dateStarted: July 1, 2025
- Recruitment status
- Completed
- Enrollment listed in the registry
- 70
- Sponsor
- Tanta University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Not clearly listed
- Locations
- Egypt
- Age range
- From 18 Years to 75 Years
- Official registry ID
- NCT07526454
- Official title
Show the full official title
Comparative Efficacy of Electroconvulsive Therapy Versus Intravenous Ketamine in Treatment-Resistant Major Depressive Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Tanta
Questions about this study
What did researchers investigate?
This study evaluated the effectiveness of ketamine for people with depression.
Who is behind this study?
The study sponsor is Tanta University, a university.
Did this study involve medication?
Yes. The study involved medication, including ketamine.
Who was this study for?
Listed age limits: 18 years to 75 years.
